Popular:
Clinical & Academic Services IEC, CTRI & Regulatory Compliance Thesis Biostatistics & Data Analysis Academic Publishing & Case Reports Pharma Career & Higher Studies B2B Pharma & Specialist Clinics All 19 Services & Fixed Prices
Stage Bundles & Custom Builder Exam Notes Library (PDF • Word • EPUB)
Free Interactive Tools Free 8-Q Thesis & Sample Size Calculator Free Naranjo & Hartwig ADR Calculator
Automated Offers & Coupon Codes
Company & Legal Policies How Ordering Works About Sciagen Client Reviews Terms, Refund & DPDP Privacy Policy Contact Us

Your Order Summary

Thesis Biostatistics & Clinical Data Analysis for Pharm.D, M.Pharm & MD/MS

Reproducible statistical computation on your empirical Excel master chart—from formula-backed sample size calculation to inferential hypothesis testing, 300-DPI figures, and complete Results chapters.

4 Modular ServicesFrom ₹849SPSS / R / Python 300-DPI OutputZero Data Fabrication Guarantee

Standard turnaround is counted in working days from receipt of your 50% advance and complete de-identified data. Express Priority delivery (+25%) is available on eligible services.

STAT-01

STAT-01

Formula-backed sample size and statistical power derivation dossier (Cochran, Daniel, Charan-Biswas, or two-group power equations) with 10% attrition adjustment and literature citation ready for IEC submission.

Book Now
Inspect Deliverable Structure

Sample Power Derivation

Alpha = 0.05 (95% CI), Power = 80%, Effect Size = 0.50 → Base n = 128 (64/group); With 10% Attrition N = 143 subjects.

STAT-02

STAT-02

Raw Excel master chart cleaning, variable coding, missing-data audit, Shapiro-Wilk / Kolmogorov-Smirnov normality testing, descriptive tables (Mean ± SD, Median + IQR, n/%), and baseline demographic charts for up to 150 subjects and 20 variables.

Book Now
Inspect Deliverable Structure

Sample Baseline Table

Age (Mean ± SD): Group A 42.4 ± 9.6 vs Group B 43.8 ± 10.1 (p = 0.41) | HbA1c Median (IQR): 7.6 (6.9–8.4)

STAT-03

STAT-03

Complete inferential biostatistics for up to 250 subjects, 20 variables, and 3 study objectives—covering parametric/non-parametric tests (t-test, ANOVA + Tukey, Mann-Whitney, Wilcoxon, Chi-square/Fisher's, correlation/regression, ROC/forest/box plots at 300 DPI) plus a written APA/Vancouver Results & Interpretation chapter.

Book Now
Inspect Deliverable Structure

Sample Inferential Output

Unpaired t-test: t = 2.84, p = 0.005 | One-Way ANOVA with Tukey HSD: F = 6.12, p = 0.003 | Chi-Square: χ² = 7.45, p = 0.006

STAT-04

STAT-04

Comprehensive Drug Utilization Evaluation (DUE) and prescription audit for up to 300 encounters evaluated against WHO/INRUD core prescribing indicators, ATC/DDD classification, polypharmacy index, and essential medicines compliance.

Book Now
Inspect Deliverable Structure

Sample WHO Indicator Audit

Avg drugs/encounter: 3.2 (WHO ref 1.6–1.8) | Generic prescribing: 54% | Antibiotic encounters: 38% | EML compliance: 84%